Free Trial

OLD National Bancorp IN Cuts Stock Position in CVS Health Co. (NYSE:CVS)

CVS Health logo with Retail/Wholesale background

OLD National Bancorp IN decreased its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 12.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 247,960 shares of the pharmacy operator's stock after selling 35,746 shares during the period. OLD National Bancorp IN's holdings in CVS Health were worth $11,131,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the stock. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health in the 3rd quarter worth about $25,000. Ridgewood Investments LLC raised its position in shares of CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after acquiring an additional 450 shares in the last quarter. Livelsberger Financial Advisory bought a new position in shares of CVS Health in the 3rd quarter worth approximately $31,000. Legacy Investment Solutions LLC bought a new position in shares of CVS Health in the 3rd quarter worth approximately $31,000. Finally, Reston Wealth Management LLC bought a new position in shares of CVS Health in the 3rd quarter worth approximately $32,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. TD Cowen raised their price objective on CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a research report on Monday, November 25th. Piper Sandler cut their target price on CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research note on Monday, November 25th. StockNews.com downgraded CVS Health from a "hold" rating to a "sell" rating in a research note on Thursday, November 14th. Evercore ISI raised their price target on CVS Health from $60.00 to $65.00 and gave the stock an "outperform" rating in a research note on Monday. Finally, Deutsche Bank Aktiengesellschaft upgraded CVS Health from a "hold" rating to a "buy" rating and set a $66.00 target price on the stock in a research report on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, CVS Health presently has an average rating of "Moderate Buy" and an average price target of $68.12.

Check Out Our Latest Analysis on CVS Health

CVS Health Stock Down 0.1 %

NYSE:CVS traded down $0.06 during trading hours on Thursday, reaching $56.84. The company's stock had a trading volume of 11,117,991 shares, compared to its average volume of 13,518,829. The company has a market capitalization of $71.53 billion, a P/E ratio of 14.43, a price-to-earnings-growth ratio of 0.80 and a beta of 0.59. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a 50 day moving average price of $51.28 and a two-hundred day moving average price of $56.17.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same period in the prior year, the firm earned $2.21 EPS. The firm's revenue was up 6.3% on a year-over-year basis. Equities analysts predict that CVS Health Co. will post 5.22 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.68%. CVS Health's payout ratio is 67.51%.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Should You Invest $1,000 in CVS Health Right Now?

Before you consider CVS Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.

While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear energy is making a resurgence! Watch to find out which seven nuclear energy stocks could deliver long-term gains in the transition to cleaner energy.

Related Videos

Pelosi Bets Big on AI: Her Top 5 Stock Picks
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines